Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2006-09-12
2006-09-12
Lilling, Herbert J. (Department: 1651)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S252100, C424S093450
Reexamination Certificate
active
07105336
ABSTRACT:
Strains ofLactobacilluswhich have been selected for their capability of reducing gastrointestinal inflammation, such as that due toHelicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated withHelicobacter pylorifor administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.
REFERENCES:
patent: 5439678 (1995-08-01), Dobrogosz et al.
patent: 5458875 (1995-10-01), Casas et al.
patent: 5534253 (1996-07-01), Casas et al.
patent: 5674901 (1997-10-01), Cook et al.
patent: 5827885 (1998-10-01), Cook et al.
patent: 5837238 (1998-11-01), Casas et al.
patent: 5849289 (1998-12-01), Dobrogosz et al.
patent: 6020376 (2000-02-01), Pariza et al.
patent: 6562629 (2003-05-01), Lin et al.
patent: 6805852 (2004-10-01), Lin et al.
patent: 6861053 (2005-03-01), Lin et al.
patent: 6872565 (2005-03-01), Mollstam et al.
Christensen et al., Paper entitled “Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells”, J. Immunol. 168: 171-178, 2002.
Ehejom, Thesis entitled Presence ofLactobacillusssp. in the Human Stomach and Their Effects onHelicobacter pylori, Uppsala Universitet, Examensarbete, Jun. 2000.
Maasen et al., Paper entitled Strain-dependent induction of cytokine profiles in the gut by orally administeredLactobacillusstrains, Vaccine 18(23): 2613-23, 2000.
Mahdavi et al., Paper entitled “Helicobacter pyloriSabA Adhesion in Persistent Infection and Chronic Inflammation”, Science 297:573-578, 2002.
Mukai et al., Paper entitled Inhibition of binding ofHelicobacter pylorito the glycolipid receptors by probioticLactobacillus reuteri, FEMS Immunol. & Med. Microbiol. 32: 105-110, 2002.
Sakamoto et al., Paper entitled “Suppressive effect ofLactobacillus gasseriOLL 2716 (LG21) onHelicobactere pyloriinfection in humans”, J. Antimicrobiol. Chemotherapy 47: 709-710, 2001.
Tejada-Simon et al., Abstract entitled “Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model”, J. Food. Prot. 62(2): 162-9, 1999; and.
Thalmaker et al., Abstract entitled “Role of Tumor Necrosis Factor Alpha inHelicobacter pyloriGastritis in Tumor Necrosis Factor Receptor 1-Deficient Mice”, Infect. Immun. 70(6): 3149-55, 2002.
Connolly Eamonn
Mollstam Bo
Barber Lynn E.
Biogaia AB
Lilling Herbert J.
LandOfFree
Selection and use of lactic acid bacteria for reducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selection and use of lactic acid bacteria for reducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selection and use of lactic acid bacteria for reducing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3604975